003017.SZ Stock - Zhejiang Dayang Biology Technology Co.,Ltd.
Unlock GoAI Insights for 003017.SZ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $909.96M | $919.45M | $1.06B | $783.21M | $678.34M |
| Gross Profit | $177.90M | $166.28M | $146.25M | $152.16M | $165.69M |
| Gross Margin | 19.6% | 18.1% | 13.8% | 19.4% | 24.4% |
| Operating Income | $75.37M | $56.29M | $59.19M | $79.33M | $101.71M |
| Net Income | $63.75M | $50.01M | $80.73M | $70.01M | $91.61M |
| Net Margin | 7.0% | 5.4% | 7.6% | 8.9% | 13.5% |
| EPS | $0.78 | $0.62 | $0.99 | $0.83 | $2.04 |
Zhejiang Dayang Biology Technology Co.,Ltd. engages in research and development, production, and sale of biological products, agricultural chemicals, and chemical in China and internationally. The company's products include food additive potassium carbonate, potassium carbonate, food additive potassium bicarbonate, potassium bicarbonate, agricultural grade ammonium chloride, and industrial grade ammonium chloride. It also offers chemical products, such as 2-chloro-6-fiuorobenzaldehyde, 2-chloro-6-fluorobenzyl chloride, and anisole products; veterinary APIs, including amprolium HCL; and veterinary drug premixes comprising enramycin premixes. The company was founded in 1976 and is based in Jiande, China.
Visit WebsiteEarnings History & Surprises
003017.SZEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 30, 2025 | — | $0.36 | — | — |
Q2 2025 | Jun 30, 2025 | — | $0.26 | — | — |
Q2 2025 | May 21, 2025 | — | $0.15 | — | — |
Q1 2025 | Mar 31, 2025 | — | $0.36 | — | — |
Q3 2024 | Sep 29, 2024 | — | $0.24 | — | — |
Q2 2024 | Jun 29, 2024 | — | $0.18 | — | — |
Q2 2024 | May 21, 2024 | — | $0.12 | — | — |
Q1 2024 | Mar 31, 2024 | — | $0.21 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.20 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.06 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.24 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.38 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.21 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.48 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.14 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.01 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.28 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.46 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.42 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.31 | — | — |
Latest News
Frequently Asked Questions about 003017.SZ
What is 003017.SZ's current stock price?
What is the analyst price target for 003017.SZ?
What sector is Zhejiang Dayang Biology Technology Co.,Ltd. in?
What is 003017.SZ's market cap?
Does 003017.SZ pay dividends?
Similar Stocks
Basic Materials SectorExplore stocks similar to 003017.SZ for comparison